InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,037.59
(
1.06%
)
US TECH 100
21,180.00
(
-0.09%
)
Dow Jones
43,325.80
(
0.07%
)
Brent Oil
72.89
(
0.00%
)
Bitcoin
95,688.91
(
0.00%
)
Post# of 254029
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JohnWayne

Send PM Follow Ignore
Followers 6
Posts 271
Boards Moderated 0
Alias Born 12/22/2011

JohnWayne

Re: DewDiligence post# 241667

Monday, 03/07/2022 3:13:24 PM

Monday, March 07, 2022 3:13:24 PM

Post# of 254029
Study was initiated well in advance of any pivotal trial readouts in favor of neoadjuvant or adjuvant IO, so control arm is unsurprising in that respect. Merck, Roche and AstraZeneca all have very similar studies too

https://clinicaltrials.gov/ct2/show/NCT03425643

https://clinicaltrials.gov/ct2/show/NCT03456063

https://clinicaltrials.gov/ct2/show/NCT03800134
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up